Asian Spectator


The Times

.

Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo

  • Written by Christine Coughlin, Professor of Law, Wake Forest University
Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limboIn addition to evaluating new drug applications, the FDA also inspects drug manufacturing facilities.The U.S. Food and Drug Administration/Flickr

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and...

Magazine

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

hacklink hack forum hacklink film izle hacklink z-librarytelegram下载matbetgrandpashabet hangi ülkeningrandpashabet giriş xgrandbettingtelegram webbetasus girişcasibomdeneme bonusu veren sitelercasibomdeneme bonusugrandpashabetagen bolajojobetholiganbetholiganbetjojobetjojobetjojobetcasibom